Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome- |
RCV001807559 | SCV002054619 | benign | Primary erythromelalgia | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807560 | SCV002054620 | benign | Channelopathy-associated congenital insensitivity to pain, autosomal recessive | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001807561 | SCV002054621 | benign | Paroxysmal extreme pain disorder | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594593 | SCV005087390 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 76% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 71. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV004710380 | SCV005241943 | benign | not provided | criteria provided, single submitter | not provided |